Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix<sup>®</sup>) in VZV Seronegative Immunocompromised Adults
<b>Background:</b> Immunocompromised patients are at risk of severe varicella zoster virus (VZV) infection and reactivation. In VZV seronegative immunocompromised persons, live-attenuated VZV vaccination is contraindicated, thus the recombinant herpes zoster vaccine (rHZV) remains a safe...
Saved in:
Main Authors: | Andrea Wessely, Ines Zwazl, Melita Poturica, Lukas Weseslindtner, Michael Kundi, Ursula Wiedermann, Angelika Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/7/737 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Approach for Diagnostics of VZV Infection by Using Real-Time PCR
by: H. Ph. Pham, et al.
Published: (2016-10-01) -
Detection of Varicella Zoster Virus Reactivation in Cerebrospinal Fluid in Ischemic Stroke or Transient Ischemic Attack
by: Wenyang Li, et al.
Published: (2025-07-01) -
Microvascular Density Analysis of Patients with Trigeminal Herpes Zoster—An Optical Coherence Tomography Angiography Study
by: Eliane Luisa Esser, et al.
Published: (2025-07-01) -
Agonists of Receptors of the Innate Immunity and Defective Viral Particles as New Generation of Adjuvants
by: O. A. Svitich, et al.
Published: (2018-02-01) -
Primary Varicella Pneumonia in an Adult With Robust Immune Status: A Case Report
by: Sunil Bhatta, et al.
Published: (2025-07-01)